CTOs on the Move

Humacyte

www.humacyte.com

 
Humacyte, Inc. (Nasdaq: HUMA) is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. The Company develops and manufactures acellular tissues to treat a wide range of diseases, injuries and chronic conditions. Humacyte`s initial opportunity, a portfolio of human acellular vessels (HAVs), is currently in late-stage clinical trials targeting multiple vascular applications, including vascular trauma repair, arteriovenous access for hemodialysis, and peripheral arterial disease. Preclinical development is also underway in coronary artery bypass grafts, pediatric heart surgery, treatment of type 1 diabetes, ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.humacyte.com
  • 2525 E NC Highway 54
    Durham, NC USA 27713
  • Phone: 919.313.9633

Executives

Name Title Contact Details
Heather Prichard
Chief Operating Officer Profile

Funding

Humacyte raised $150M on 10/20/2015
Humacyte raised $18M on 10/02/2017
Humacyte raised $150M on 06/11/2018
Humacyte raised $50M on 04/14/2021
Humacyte raised $38M on 04/14/2021

Similar Companies

Forus Health

Forus Health is a medical technology start up founded in 2010 by a group of engineers with the goal to eradicate avoidable blindness. Over the years Forus Health has designed and developed affordable technology solutions to increase access and affordability of eye care. Our first product 3nethra classic is a compact and portable non-mydriatic fundus camera used for capturing digital images of the posterior (retina) and anterior (cornea) segments of the eye. The device is used for identifying common eye problems such as diabetic retinopathy, glaucoma, ARMD, cataract etc. The device is also integrated to a cloud based telemedicine platform which enables remote diagnosis. There are 40 million people who are blind globally, and 15 million live in India. The high incidence of blindness in India is due to a combination of several issues, but mostly due to limited access to eye care facilities, high cost of treatment/surgery and lack of awareness. The objective of Forus Health is to use technology to increase access, bring down the cost of diagnosis(affordability) and raise awareness (the three As). The key to our solution is not just the technology, but the way in which we have designed the deployment of the product.

UpStream Care

UpStream is the fastest-growing primary healthcare solution provider in the US. We underwrite and support the delivery of value-based care for older patients and people living with chronic conditions. By working in partnership with healthcare practices and clinics we offer a comprehensive risk-free solution for physicians that finances, delivers and sustains better outcomes for everyone. UpStream`s proven risk-free solution for physicians is called GAP-QTM (Guaranteed Advanced Payments for Quality). It combines global risk-management services with embedded professional services — all facilitated and integrated by our state of the art digital platform. GAP-QTM benefits physicians and practices through increased income and professional satisfaction. Patients benefit through reduced hospital admissions, reduced copayments, increased benefits and satisfaction, and improved health. Their informal caregivers also benefit from the significantly reduced burden and stress.

University Medicines

University Medicines is a Sunnyvale, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Proteogenomics Research Institute for Systems Medicine (PRISM)

Proteogenomics Research Institute for Systems Medicine (PRISM) is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Meadowview Manor Retirement HM

Meadowview Manor Retirement HM is a Mc Veytown, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.